Cumulative incidence of venous thromboembolism (VTE) accounting for competing risk (death of any cause other than fatal VTE) according to expression levels of podoplanin. Podoplanin expression was associated with a significantly increased risk of VTE; the probability of VTE increased with increasing levels of podoplanin staining intensity. Log-rank test comparing the cause-specific hazards of VTE (null hypothesis: all 4 podoplanin staining groups have the same VTE rate): P = .019; Gray’s test comparing the competing risk cumulative incidences (null hypothesis: all 4 podoplanin staining groups have the same VTE risk): P = .062.